◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Global X Aging Population ETF (AGNG) ETF Overview

Name: Global X Aging Population ETF (AGNG) price history and fund statistics
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Price history, fund statistics and profile — an exchange-traded fund.

Exchange-Traded Funds · Health · DATA UPDATED 2026-08-31

Global X Aging Population ETF (AGNG) is an exchange-traded fund managed by Global X Funds in the "Health" category. It manages roughly $87 million in assets.

The fund invests more than 80% of its total assets in the securities of the underlying index.

Interactive chart & fund stats →

AGNG Fund Statistics

Expense ratio	0.50%
Trailing yield	0.88%
Assets under management	$87 million
Fund category	Health
Fund family	Global X Funds
Inception	2016-05-09

The live price chart, fund profile and news are in the interactive AGNG viewer.

Other Companies in Health

PSCH · Invesco S&P SmallCap Health Care ETF — $165 million
XHE · State Street SPDR S&P Health Care Equipment ETF — $159 million
LFSC · F/m Emerald Life Sciences Innovation ETF — $125 million
BBP · Virtus LifeSci Biotech Products ETF — $99 million
GNOM · Global X Genomics & Biotechnology ETF — $80 million
SURI · Simplify Propel Opportunities ETF — $78 million
IBBQ · Invesco Nasdaq Biotechnology ETF — $76 million
HTEC · Robo Global Healthcare Technology and Innovation ETF — $69 million

← AGNC All “A” companies AGNT →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.